These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. "Topical immunomodulators?": introducing old friends and a new ally, tacrolimus. Nghiem P J Am Acad Dermatol; 2001 Jan; 44(1):111-3. PubMed ID: 11148486 [No Abstract] [Full Text] [Related]
7. Suppressive effects of topical mometasone furoate and tacrolimus on skin prick testing in children. Gradman J; Wolthers OD Pediatr Dermatol; 2008; 25(2):269-70. PubMed ID: 18429800 [TBL] [Abstract][Full Text] [Related]
8. Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis. Ingram JR; Martin JA; Finlay AY Am J Clin Dermatol; 2009; 10(4):229-37. PubMed ID: 19489656 [TBL] [Abstract][Full Text] [Related]
9. Topical tacrolimus and cancer (continued). Do not use. Prescrire Int; 2009 Jun; 18(101):122. PubMed ID: 19639677 [No Abstract] [Full Text] [Related]
10. The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitis. Reitamo S; Mandelin J; Rubins A; Remitz A; Mäkelä M; Cirule K; Rubins S; Zigure S; Ho V; Dickinson J; Undre N Int J Dermatol; 2009 Apr; 48(4):348-55. PubMed ID: 19335418 [TBL] [Abstract][Full Text] [Related]
11. Alcohol intolerance and facial flushing in patients treated with topical tacrolimus. Milingou M; Antille C; Sorg O; Saurat JH; Lübbe J Arch Dermatol; 2004 Dec; 140(12):1542-4. PubMed ID: 15611445 [No Abstract] [Full Text] [Related]
12. [Topical immune modulation and risk of cancer]. Deleuran M; Zachariae C; Thestrup-Pedersen K Ugeskr Laeger; 2009 Aug; 171(35):2468-71. PubMed ID: 19732533 [TBL] [Abstract][Full Text] [Related]
13. Wet-wrap treatment using dilutions of tacrolimus ointment and fluticasone propionate cream in human APOC1 (+/+) mice with atopic dermatitis. Oranje AP; Verbeek R; Verzaal P; Haspels I; Prens E; Nagelkerken L Br J Dermatol; 2009 Jan; 160(1):54-61. PubMed ID: 18795918 [TBL] [Abstract][Full Text] [Related]
14. [The practice guideline 'Atopic dermatitis' (first revision) from the Dutch College of General Practitioners; a response from the perspective of dermatology]. Bruijnzeel-Koomen CA Ned Tijdschr Geneeskd; 2007 Jun; 151(25):1387. PubMed ID: 17668600 [TBL] [Abstract][Full Text] [Related]
15. [Tacrolimus ointment for the treatment of atopic dermatitis]. Ohtsuki M Arerugi; 2009 May; 58(5):499-506. PubMed ID: 19487830 [No Abstract] [Full Text] [Related]
16. Topical use of pimecrolimus in atopic dermatitis: update on the safety and efficacy. Werfel T J Dtsch Dermatol Ges; 2009 Sep; 7(9):739-42. PubMed ID: 19650820 [TBL] [Abstract][Full Text] [Related]
17. Effects of tacrolimus ointment on the expression of substance P, nerve growth factor, and neurotrophin-3 in atopic dermatitis. Kim HO; Lee CH; Ahn HK; Park CW Int J Dermatol; 2009 Apr; 48(4):431-8. PubMed ID: 19335435 [TBL] [Abstract][Full Text] [Related]
19. Atopic dermatitis. Ong PY; Boguniewicz M Prim Care; 2008 Mar; 35(1):105-17, vii. PubMed ID: 18206720 [TBL] [Abstract][Full Text] [Related]
20. Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption. Pariser D Am J Ther; 2009; 16(3):264-73. PubMed ID: 19262357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]